Poor glycemic control is related to increased nitric oxide activity within the renal circulation of patientswith type 2 diabetes

Diabetes Care

Volumn 36, Issue 12, 2013, Pages 4071-4075

  Schneider, Markus P ^a   Ott, Christian ^a   Schmidt, Stephanie ^a   Kistner, Iris ^a   Friedrich, Stefanie ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HEMOGLOBIN; N(G) METHYLARGININE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYMURIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; AGED; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; GLYCEMIC INDEX; KIDNEY; KIDNEY CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RENAL CIRCULATION;

EID: 84891851622     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0806     Document Type: Article

References (31)

1. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2012 Annual Data Report (Abstract). Am J Kidney Dis 2013; 61(Suppl 1):A7
2. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? Ameta-analysis. Diabetologia 2009; 52:691-697
3. Dahlquist G, Stattin EL, Rudberg S. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term followup study of childhood onset type-1 diabetic patients. Nephrol Dial Transplant 2001;16: 1382-1386
4. Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE. Assessment of endothelial function of the renal vasculature in human subjects. Am J Hypertens 2002;15:3-9
5. Delles C, Klingbeil AU, Schneider MP, Handrock R, Schaufele T, Schmieder RE. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant 2004;19:1392-1397
6. Wolzt M, Schmetterer L, Ferber W, et al. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol 1997; 272:F178-F182
7. Sugimoto H, Shikata K, Matsuda M, et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 1998; 41:1426-1434
8. Ito A, Uriu K, Inada Y, et al. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin induced diabetic rat. J Lab Clin Med 2001; 138:177-185
9. Mattar AL, Fujihara CK, Ribeiro MO, de Nucci G, Zatz R. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron 1996;74:136-143
10. Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000;11:71-79
11. Levine DZ, Iacovitti M, Robertson SJ, Mokhtar GA. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2006;290:R975-R981
12. Thomson SC, Deng A, Komine N, Hammes JS, Blantz RC, Gabbai FB. Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am J Physiol Renal Physiol 2004;287:F732-F738
13. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997;96:25-28
14. Flores C, Rojas S, Aguayo C, et al. Rapid stimulation of L-arginine transport by D-glucose involves p42/44(mapk) and nitric oxide in human umbilical vein endothelium. Circ Res 2003;92:64-72
15. Kasai N, Sugimoto K, Horiba N, Suda T. Effect of D-glucose on nitric oxide release from glomerular endothelial cells. Diabetes Metab Res Rev 2001;17:217-222
16. Hiragushi K, Sugimoto H, Shikata K, et al. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo-and micro-albuminuric patients with type 2 diabetes. Diabetes Res Clin Pract 2001;53:149-159
17. Apakkan Aksun S, Ozmen B, Ozmen D, et al. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration. J Diabetes Complications 2003;17:343-348
18. Chiarelli F, Cipollone F, Romano F, et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000; 49:1258-1263
19. Cherney DZ, Reich HN, Jiang S, et al. Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2012;303:R710-R718
20. Schneider MP, Schlaich MP, Harazny JM, et al. Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity (Silver Spring) 2011;19:960-967
21. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. The Renal Clearances of Substituted Hippuric Acid Derivatives and Other Aromatic Acids in Dog and Man. J Clin Invest 1945;24:388-404
22. Bode-Böger SM, Scalera F, Ignarro LJ. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 2007;114:295-306
23. Edwards RM, Trizna W. Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors. J Am Soc Nephrol 1993;4:1127-1132
24. Ito S, Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 1993;92:1093-1098
25. Carmines PK, Perry MD, Hazelrig JB, Navar LG. Effects of preglomerular and postglomerular vascular resistance alterations on filtration fraction. Kidney Int Suppl 1987;20:S229-S232
26. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urinedwhat does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 1998;7:59-62
27. Cherney DZ, Scholey JW, Sochett EB. Sex Differences in Renal Responses to Hyperglycemia, L-arginine, and L-NMMA in Humans With Uncomplicated Type 1 Diabetes Mellitus. Diabetes Care 2013;36: 1290-1296
28. Cherney DZ, Miller JA, Scholey JW, et al. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes 2008; 57:688-695
29. Viberti GC, Benigni A, Bognetti E, Remuzzi G, Wiseman MJ. Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitus. Diabet Med 1989;6:219-223
30. Sorrenti V, Mazza F, Campisi A, Vanella L, Li Volti G, Di Giacomo C. High glucosemediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Curr Neurovasc Res 2006;3:49-54
31. Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985;312:617-621